Showing 31 - 40 of 70
Persistent link: https://www.econbiz.de/10012005736
Persistent link: https://www.econbiz.de/10011745278
Persistent link: https://www.econbiz.de/10011745302
Persistent link: https://www.econbiz.de/10011801801
The National Institute for Health and Care Excellence (NICE) invited the manufacturer of ruxolitinib (Novartis) to submit clinical and cost-effectiveness evidence for ruxolitinib within its licensed indication (the treatment of disease-related splenomegaly or symptoms in adult patients with...
Persistent link: https://www.econbiz.de/10011001556
Persistent link: https://www.econbiz.de/10004122088
Persistent link: https://www.econbiz.de/10007390940
Persistent link: https://www.econbiz.de/10005929970
Persistent link: https://www.econbiz.de/10005992813
Persistent link: https://www.econbiz.de/10006874881